<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Hum Genet</journal-id><journal-id journal-id-type="iso-abbrev">Indian J Hum Genet</journal-id><journal-id journal-id-type="publisher-id">IJHG</journal-id><journal-title-group><journal-title>Indian Journal of Human Genetics</journal-title></journal-title-group><issn pub-type="ppub">0971-6866</issn><issn pub-type="epub">1998-362X</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3897137</article-id><article-id pub-id-type="publisher-id">IJHG-19-423</article-id><article-id pub-id-type="doi">10.4103/0971-6866.124370</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Distribution and genotype frequency of the C1431T and pro12ala polymorphisms of the peroxisome proliferator activator receptor gamma gene in an Iranian population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rooki</surname><given-names>Hassan</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Haerian</surname><given-names>Monir-Sadat</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Azimzadeh</surname><given-names>Pedram</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Ebrahimi</surname><given-names>Mahmoud</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Mirhafez</surname><given-names>Reza</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Ferns</surname><given-names>Gordon</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Ghayour-Mobarhan</surname><given-names>Majid</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Zali</surname><given-names>Mohammad-Reza</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1">Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</aff><aff id="aff2"><label>1</label>Cardiovascular Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</aff><aff id="aff3"><label>2</label>Institute for Science and Technology in Medicine, University of Keele, Guy Hilton Research Centre, Thornburrow Drive, Stok on Trent, Staffordshire, United Kingdom</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Prof. Mohammad-Reza Zali, 7<sup>th</sup> Floor, Taleghani Hospital, Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences, Velenjak, Shahid Aerabi Street, Yemen Street, Tehran, Iran. E-mail: <email xlink:href="nnzali@hotmail.com">nnzali@hotmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2013</year></pub-date><volume>19</volume><issue>4</issue><fpage>423</fpage><lpage>429</lpage><permissions><copyright-statement>Copyright: &#169; Indian Journal of Human Genetics</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>BACKGROUND:</title><p>Peroxisome proliferator activator receptor gamma (PPAR&#947;) is a nuclear transcription factor regulating multiple genes involved in cell growth, differentiation, carbohydrate and lipid metabolism and energy production. Several genetic variations in the PPAR&#947; gene have been identified to be associated with diabetes, obesity, dyslipidemia, insulin resistance, metabolic syndrome and coronary artery disease. The present study was designed to explore the distribution of two common single nucleotide polymorphisms of the PPAR&#947; gene (C1431T and Pro12Ala) in an Iranian population.</p></sec><sec id="st2"><title>MATERIALS AND METHODS:</title><p>Genotype frequencies for these two polymorphisms were compared for 160 healthy Iranian individuals with reports from other populations. The Genotyping was performed using real-time polymerase chain reaction.</p></sec><sec id="st3"><title>RESULTS:</title><p>The genotype distribution of the C1431T PPAR&#947; polymorphism was 0.869 for the CC genotype, 0.119 for the CT genotype and 0.013 for uncommon TT genotype. Allelic frequencies were 0.93 for C and 0.07 for T allele respectively. For the Pro12Ala polymorphism of PPAR&#947; gene, genotypic distributions and allelic frequencies were, 0.813 for CC, 0.181 for CG and 0.06 for GG and 0.903 for C and 0.097 for G respectively. Allelic and genotypic frequencies for both polymorphisms of PPAR&#947; gene were in Hardy-Weinberg equilibrium.</p></sec><sec id="st4"><title>CONCLUSIONS:</title><p>Iran is a country with an ethnically diverse population and a comparison of allelic and genotypic frequencies of PPAR&#947; C1431T and Pro12Ala polymorphisms between our population and others showed significant differences.</p></sec></abstract><kwd-group><kwd>Iranian population</kwd><kwd>PPAR&#947; gene</kwd><kwd>single nucleotide polymorphism</kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title>Introduction</title><p>Peroxisome proliferator activator receptor gamma (PPAR&#947;) is a member of the nuclear receptor superfamily and is a ligand-activated transcription factor that regulates genes responsible for some very important biological functions including: Cell growth, differentiation and metabolism and acts as dietary lipid sensor.[<xref ref-type="bibr" rid="ref1">1</xref>]</p><p>The PPAR&#947; gene is located on the human chromosome 3p25-24 and consists of nine exons and as a result of alternative splicing and promoter usage produces four isoforms; PPAR&#947;1, PPAR&#947;2, PPAR&#947;3 and PPAR&#947;4. PPAR&#947;1 is expressed by most tissues.[<xref ref-type="bibr" rid="ref2">2</xref>] PPAR&#947;2 is predominantly expressed in adipose tissue and regulates adipocyte differentiation.[<xref ref-type="bibr" rid="ref3">3</xref>] PPAR&#947;3 expression appears to be confined to macrophages, adipose tissue and the colon.[<xref ref-type="bibr" rid="ref4">4</xref>] Primer extension studies have confirmed that PPAR&#947;4 mRNA is present in adipose tissue suggesting that the PPAR&#947;4 isoform has a role in adipocyte biology.[<xref ref-type="bibr" rid="ref5">5</xref>]</p><p>PPAR&#947; plays critical roles in regulating lipid and carbohydrate metabolism (energy balance), adipocyte differentiation, proliferation and insulin sensitivity and create a relationship between environmental factors and metabolic processes of the organism.[<xref ref-type="bibr" rid="ref6">6</xref>] PPAR&#947; also plays roles in macrophages by enhancing foam cell formation and suppressing inflammatory cytokine production. It may also participate in controlling systemic glucose and lipid metabolism in the liver.[<xref ref-type="bibr" rid="ref7">7</xref><xref ref-type="bibr" rid="ref8">8</xref>] PPAR&#947; may therefore affect processes involved in atherosclerosis.[<xref ref-type="bibr" rid="ref9">9</xref>]</p><p>Since PPAR&#947; is a nuclear transcription factor regulating multiple genes involved in energy production, glucose and lipid metabolism it may be a promising candidate gene for several major common diseases including cardiovascular disease, cancer, diabetes, inflammation and polymorphisms in this receptor may influence the pathology of these diseases. The PPAR&#947; gene has been reported to be associated with various metabolic disorders including diabetes,[<xref ref-type="bibr" rid="ref10">10</xref>] obesity,[<xref ref-type="bibr" rid="ref11">11</xref>] dyslipidemia, insulin resistance, metabolic syndrome[<xref ref-type="bibr" rid="ref12">12</xref>] and coronary artery disease (CAD).[<xref ref-type="bibr" rid="ref13">13</xref>]</p><p>Several PPAR&#947;2 gene single nucleotide polymorphisms (SNPs) have been reported to be associated with diabetes, obesity, dyslipidemia, insulin resistance, metabolic syndrome and CAD. Several genetic variations of the PPAR gene have been found in the activation function domain 1, deoxyribonucleic acid binding domain and ligand binding domain (LBD) of the receptor and confer some conformational changes in protein structure that may affect transcriptional activity.[<xref ref-type="bibr" rid="ref14">14</xref>]</p><p>Among several genetic variants of the PPAR&#947; gene, two polymorphisms Pro12Ala of the exon B (rs1801282) and the C1431T silent substitution (rs3856806) in the 6<sup>th</sup> exon are the most frequently occurring SNPs and have been associated with various diseases and extensive studies have been undertaken to assess the effects of these polymorphisms on many aspects of human physiology. The C1431T polymorphism is also known as the C161T or His477His was identified in 1998 by Meirhaeghe <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref15">15</xref>] and has been studied in relation to bone metabolism, metabolic syndrome, CAD, obesity and glucose intolerance. The Pro12Ala protein polymorphism is due to a CCA-to-GCA missense mutation and was identified by Yen <italic>et al</italic>.[<xref ref-type="bibr" rid="ref16">16</xref>] It is associated with type-2 diabetes mellitus, insulin resistance, obesity and metabolic disorders. In addition, numerous studies have demonstrated rare alleles of these two common variants play a role in the complex pathogenetic mechanism of major diseases supposed to be useful markers to evaluate the connection between PPAR&#947; and metabolic derived disorders.</p><p>Given the pivotal roles of PPAR&#947; in regulating metabolism several studies in various ethnic populations including, Caucasians,[<xref ref-type="bibr" rid="ref17">17</xref>] Mexican-Americans,[<xref ref-type="bibr" rid="ref18">18</xref>] African-Americans,[<xref ref-type="bibr" rid="ref19">19</xref><xref ref-type="bibr" rid="ref13">13</xref>] Asian,[<xref ref-type="bibr" rid="ref20">20</xref>] Eastern Asian,[<xref ref-type="bibr" rid="ref12">12</xref>] European,[<xref ref-type="bibr" rid="ref10">10</xref>] Hispanic and non-Hispanic[<xref ref-type="bibr" rid="ref21">21</xref>] have been conducted to determine allelic frequencies and genotypic distribution. There have been no studies of the distribution of C1431T polymorphism in an Iranian population and there is some controversy about the frequency of Pro12Ala polymorphism. Therefore, the present study was designed to explore the distribution of these two common variants of PPAR gene in Iranian population and compare the finding with other populations. A number of 160 healthy individuals were analyzed to evaluate the frequency of PPAR&#947; alleles and genotypes in a healthy Iranian population.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><p>A total of 160 healthy volunteer subjects comprised of 70 males and 90 females, mainly people of Iranian descent (primarily Persian), were selected randomly from all parts of Mashhad as a second largest city in Iran and enrolled in this study. A health questionnaire, including questions such as name, ethnicity, family history, age, sex and dietary habits, was provided to each participant. Blood was taken in accordance with the World Health Organization protocol for blood donation and the healthy state of the all the participants was determined by medical history, physical examination and blood chemistry tests. Subjects were excluded from the study if they had a history of congestive heart disease, liver and/or renal disease, endocrinological abnormalities and alcohol consumption or were under medications that altered blood pressure, glucose or lipid metabolism. The clinical and biochemical characteristics of the all the individuals enrolled into the study were normal at baseline. The protocol was approved by the Ethics Committee of the Mashhad University of Medical Science and Informed consent was obtained from all participants.</p><p>Genomic deoxyribonucleic acid (DNA) was extracted from whole blood using the FlexiGene DNA isolation Kit (Qiagen). C1431T and Pro12Ala polymorphisms of the PPAR&#947; gene were determined by a predesigned TaqMan SNP genotyping assay (Applied Biosystems). Oligonucleotides used for allelic discrimination assays for Pro12Ala and C1431T were as follows:</p><p><list list-type="bullet"><list-item><p>Context sequences for Pro/12Ala ([VIC/FAM]) (Applied Biosystems ID: C_1129864_10):</p><p>
<list list-type="bullet"><list-item><p>AACTCTGGGAGATTCTCCTATTGAC[C/G] CAGAAAGCGATTCCTTCACTGATAC</p></list-item><list-item><p>Pro12 Probe (Vic labeled): C_1129864_10-C</p></list-item><list-item><p>Ala12 Probe (Fam labeled): C_1129864_10-G.</p></list-item></list>
</p></list-item><list-item><p>Context sequences for C1431T ([VIC/FAM]) (Applied Biosystems ID: C_11922961_30):</p><p>
<list list-type="bullet"><list-item><p>ACCTCAGACAGATTGTCACGGAACA[C/T] GTGCAGCTACTGCAGGTGATCAAGA</p></list-item><list-item><p>C1431 Probe (Vic labeled): C_11922961_30-C</p></list-item><list-item><p>T1431 Probe (Fam labeled): C_11922961_30-T.</p></list-item></list>
</p></list-item></list>
</p><p>The reaction was performed in 25 &#956;l final volume with real-time polymerase chain reaction (PCR) using 96-well plates on an ABI 7500 real time PCR system (Applied Biosystems). The PCR conditions were 95&#176;C for 10 min and 40 cycles of 92&#176;C for 15 s and 60&#176;C for 1 min. Individual genotypes identification was analyzed by SDS software version 1.3 (Applied Biosystems). For genotyping quality control, duplicate samples and negative controls were included to ensure the accuracy.</p><p>Allele frequencies of two SNPs were computed using genotype data obtained from these healthy controls and were compared with those reported in other populations. Each SNP was tested for Hardy-Weinberg equilibrium (HWE) conformity. The statistical significance of the differences between genotypic distributions in populations was tested by the Chi-square (&#967;<sup>2</sup>) or Fisher's exact test using the SPSS 16.0 statistical package. (SPSS Inc., Chicago, IL) <italic>P</italic> &lt; 0.05 was considered to be significant.</p></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p>The genotype characteristics of studied individuals are shown in <xref ref-type="table" rid="T1">Table 1</xref>. Allelic and genotypic frequencies for both polymorphisms of PPAR&#947; gene were in HWE (<italic>P</italic> &#8805; 0.05) [<xref ref-type="table" rid="T1">Table 1</xref>]. The genotypic distribution of the C1431T PPAR&#947; polymorphism were 0.869 for CC, 0.119 for CT and 0.013 for TT and allelic frequencies were 0.93 for C and 0.07 for T respectively [<xref ref-type="table" rid="T1">Table 1</xref>]. For another Pro12Ala variant of PPAR&#947;, genotypic distributions and allelic frequencies were, 0.813 for CC, 0.181 for CG and 0.06 for GG and 0.903 for C and 0.097 for G respectively [<xref ref-type="table" rid="T1">Table 1</xref>]. Differences in allelic frequencies and genotype distribution of the polymorphisms between Iranian population and those reported for other populations are shown in Tables <xref ref-type="table" rid="T2">2</xref> and <xref ref-type="table" rid="T3">3</xref> respectively.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Allelic and genotypes frequency of studied population</p></caption><graphic xlink:href="IJHG-19-423-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Comparison of allelic and genotypic frequencies of PPAR&#947; C1431T variant between our population and others</p></caption><graphic xlink:href="IJHG-19-423-g002"/></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Comparison of allelic and genotypic frequencies of PPAR&#947; Pro12Ala variant between our population and others</p></caption><graphic xlink:href="IJHG-19-423-g003"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>The present study represents the examination of the PPAR&#947; gene C1431T and Pro12Ala polymorphisms distribution in Iranian healthy population and comparison with other populations. Several studies have demonstrated these two common polymorphisms of PPAR&#947; gene have a relationship with some major diseases. This current study is part of another study dealing with patients with metabolic syndrome and CADs (unpublished data); many studies have showed these two common variants of PPAR&#947; are associated with decreased risk of CAD and MS in various populations. On the other hand, C1431T polymorphism has not been studied in our population before, so this is why we selected these two common variants to evaluate in our population.</p><p>Allelic and genotypic frequencies of PPAR&#947; C1431T polymorphism in our population showed significant differences from other populations listed in <xref ref-type="table" rid="T2">Table 2</xref> except for two reports from European,[<xref ref-type="bibr" rid="ref31">31</xref><xref ref-type="bibr" rid="ref32">32</xref>] one from Italy,[<xref ref-type="bibr" rid="ref33">33</xref>] two in African-American,[<xref ref-type="bibr" rid="ref35">35</xref>] and one from sub-Saharan African population.[<xref ref-type="bibr" rid="ref35">35</xref>] Allelic but not genotypic frequencies in one report from European,[<xref ref-type="bibr" rid="ref32">32</xref>] one from Caucasian,[<xref ref-type="bibr" rid="ref17">17</xref>] one from Hispanic[<xref ref-type="bibr" rid="ref21">21</xref>] and one from Indian[<xref ref-type="bibr" rid="ref28">28</xref>] showed significant differences from what we found in our Iranian population. In all the populations the frequency of rare allele homozygote's (TT) was low (0-7%), but there was one exception for a Chinese population that showed more than 12% frequency that it might be due to small sample size.[<xref ref-type="bibr" rid="ref24">24</xref>] In general, Chinese and other Asian populations showed a higher frequency than others. In this case, our data was different from those of Asian populations and was similar to those in Australian, European and Caucasian.</p><p>With respect to Pro12Ala polymorphism, comparison of allelic and genotypic frequencies between our data and other studies listed in <xref ref-type="table" rid="T3">Table 3</xref> shows no significant differences with most of them. However there were some significant differences with two reports from China (<italic>P</italic> = 0.00),[<xref ref-type="bibr" rid="ref20">20</xref><xref ref-type="bibr" rid="ref36">36</xref>] one from Korea (<italic>P</italic> = 0.041),[<xref ref-type="bibr" rid="ref12">12</xref>] one from Asia (<italic>P</italic> = 0.00),[<xref ref-type="bibr" rid="ref20">20</xref>] and a few reports from Europe including, Italy (<italic>P</italic> = 0.003), Slovenia (<italic>P</italic> = 0.017),[<xref ref-type="bibr" rid="ref39">39</xref>] The Czech Republic (<italic>P</italic> = 0.004),[<xref ref-type="bibr" rid="ref38">38</xref>] France (<italic>P</italic> = 0.00)[<xref ref-type="bibr" rid="ref11">11</xref>] and in an African-American population (<italic>P</italic> = 0.00)[<xref ref-type="bibr" rid="ref40">40</xref>] as well. One report from Europe and one within a Caucasian population showed significance differences in allelic but not genotypic frequencies with our results.[<xref ref-type="bibr" rid="ref38">38</xref><xref ref-type="bibr" rid="ref30">30</xref>] As shown in <xref ref-type="table" rid="T3">Table 3</xref>, the CC ((Pro/Pro) genotype was the predominant form in all populations. Data are presented in <xref ref-type="table" rid="T3">Table 3</xref> shows some inconsistency among different studies in the distribution of the G (12Ala) allele that might be due to the difference in racial and ethnic groups. The highest distribution of the G (12Ala) allele belongs to European and Caucasian populations and the least is relate to Chinese and African-American populations.</p><p>Most of the population in Iran is genetically close to Caucasian and their ancestors were the Aryans who had migrated from Central Asia to Iran. The main reason for the significant differences between our data and other populations results from Iran as a country with an ethnically diverse population including Pars, Turk, Kurd, Tajik, Turkmen, Baloch and special religious such as Muslims, Zoroastrians, Jews, Christians and Assyrians. However, Iran is located along the ancient Silk Road and connected Asia to Europe and during the course of history, Iranian population has encountered foreigners including Macedonians, Arabs, Turks and Mongols on various occasion. Therefore, the population living in this country might be mixed due to contacting with others and the immigration of some people from neighboring nations.[<xref ref-type="bibr" rid="ref41">41</xref>]</p><p>Several studies have been undertaken on the association between the Pro12Ala and C1431T mutations with numerous diseases such as cardiovascular disease, cancer, diabetes, inflammation on various populations and the results showed controversy. The controversial findings related to these polymorphisms may be attributable to genetically differences in populations. Therefore, it is necessary to study in different populations to reach a general consensus in this field.</p><p>An important limitation in our study is the relatively small sample size. Further association study with a larger population base is needed to confirm our results and may be useful in understanding these SNPs roles in pathology of the main disease in the future.</p></sec><sec sec-type="conclusions" id="sec1-5"><title>Conclusion</title><p>Statistical differences in the distribution of two common polymorphisms of PPAR&#947; gene between Iranian population and others showed the importance of studying these SNPs in relation to some major diseases. Regards to Iranian different genetic with some other populations in Asia and other continents, it seems that our study confirms this difference concerning the two common PPAR&#947; polymorphisms.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was financially supported as a PhD thesis (no. 316) by Gastroenterology and Liver Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> This work was financially supported as a PhD thesis (no. 316) by Gastroenterology and Liver Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> No.</p></fn></fn-group><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desvergne</surname><given-names>B</given-names></name><name><surname>Wahli</surname><given-names>W</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptors: Nuclear control of metabolism</article-title><source>Endocr Rev</source><year>1999</year><volume>20</volume><fpage>649</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">10529898</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beamer</surname><given-names>BA</given-names></name><name><surname>Negri</surname><given-names>C</given-names></name><name><surname>Yen</surname><given-names>CJ</given-names></name><name><surname>Gavrilova</surname><given-names>O</given-names></name><name><surname>Rumberger</surname><given-names>JM</given-names></name><name><surname>Durcan</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene</article-title><source>Biochem Biophys Res Commun</source><year>1997</year><volume>233</volume><fpage>756</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9168928</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auwerx</surname><given-names>J</given-names></name></person-group><article-title>PPARgamma, the ultimate thrifty gene</article-title><source>Diabetologia</source><year>1999</year><volume>42</volume><fpage>1033</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">10447513</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fajas</surname><given-names>L</given-names></name><name><surname>Fruchart</surname><given-names>JC</given-names></name><name><surname>Auwerx</surname><given-names>J</given-names></name></person-group><article-title>PPARgamma3 mRNA: A distinct PPARgamma mRNA subtype transcribed from an independent promoter</article-title><source>FEBS Lett</source><year>1998</year><volume>438</volume><fpage>55</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">9821958</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Shali</surname><given-names>K</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Knoers</surname><given-names>N</given-names></name><name><surname>Hermus</surname><given-names>AR</given-names></name><name><surname>Tack</surname><given-names>CJ</given-names></name><name><surname>Hegele</surname><given-names>RA</given-names></name></person-group><article-title>A single-base mutation in the peroxisome proliferator-activated receptor gamma4 promoter associated with altered <italic>in vitro</italic> expression and partial lipodystrophy</article-title><source>J Clin Endocrinol Metab</source><year>2004</year><volume>89</volume><fpage>5655</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">15531525</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#225;lez S&#225;nchez</surname><given-names>JL</given-names></name><name><surname>Serrano R&#237;os</surname><given-names>M</given-names></name><name><surname>Fern&#225;ndez Perez</surname><given-names>C</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Mart&#237;nez Larrad</surname><given-names>MT</given-names></name></person-group><article-title>Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population</article-title><source>Eur J Endocrinol</source><year>2002</year><volume>147</volume><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">12370112</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tontonoz</surname><given-names>P</given-names></name><name><surname>Nagy</surname><given-names>L</given-names></name><name><surname>Alvarez</surname><given-names>JG</given-names></name><name><surname>Thomazy</surname><given-names>VA</given-names></name><name><surname>Evans</surname><given-names>RM</given-names></name></person-group><article-title>PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL</article-title><source>Cell</source><year>1998</year><volume>93</volume><fpage>241</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">9568716</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavrilova</surname><given-names>O</given-names></name><name><surname>Haluzik</surname><given-names>M</given-names></name><name><surname>Matsusue</surname><given-names>K</given-names></name><name><surname>Cutson</surname><given-names>JJ</given-names></name><name><surname>Johnson</surname><given-names>L</given-names></name><name><surname>Dietz</surname><given-names>KR</given-names></name><etal/></person-group><article-title>Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>34268</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">12805374</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marx</surname><given-names>N</given-names></name><name><surname>Sukhova</surname><given-names>G</given-names></name><name><surname>Murphy</surname><given-names>C</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Plutzky</surname><given-names>J</given-names></name></person-group><article-title>Macrophages in human atheroma contain PPARgamma: Differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes <italic>in vitro</italic></article-title><source>Am J Pathol</source><year>1998</year><volume>153</volume><fpage>17</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">9665460</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doney</surname><given-names>AS</given-names></name><name><surname>Fischer</surname><given-names>B</given-names></name><name><surname>Cecil</surname><given-names>JE</given-names></name><name><surname>Boylan</surname><given-names>K</given-names></name><name><surname>McGuigan</surname><given-names>FE</given-names></name><name><surname>Ralston</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes</article-title><source>Diabetologia</source><year>2004</year><volume>47</volume><fpage>555</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14730381</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valve</surname><given-names>R</given-names></name><name><surname>Sivenius</surname><given-names>K</given-names></name><name><surname>Miettinen</surname><given-names>R</given-names></name><name><surname>Pihlajam&#228;ki</surname><given-names>J</given-names></name><name><surname>Rissanen</surname><given-names>A</given-names></name><name><surname>Deeb</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women</article-title><source>J Clin Endocrinol Metab</source><year>1999</year><volume>84</volume><fpage>3708</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">10523018</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>E</given-names></name><name><surname>Oh</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Oh</surname><given-names>ES</given-names></name><name><surname>Baek</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Effects of two common polymorphisms of peroxisome proliferator-activated receptor-&#947; gene on metabolic syndrome</article-title><source>Arch Med Res</source><year>2006</year><volume>37</volume><fpage>86</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">16314192</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Q</given-names></name><name><surname>Jacobs</surname><given-names>DR</given-names><suffix>Jr</suffix></name><name><surname>Schreiner</surname><given-names>PJ</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name><name><surname>Steffes</surname><given-names>MW</given-names></name><name><surname>Fornage</surname><given-names>M</given-names></name></person-group><article-title>Patterns of association between PPARgamma genetic variation and indices of adiposity and insulin action in African-Americans and whites: The CARDIA Study</article-title><source>J Mol Med (Berl)</source><year>2006</year><volume>84</volume><fpage>955</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">16955276</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agostini</surname><given-names>M</given-names></name><name><surname>Schoenmakers</surname><given-names>E</given-names></name><name><surname>Mitchell</surname><given-names>C</given-names></name><name><surname>Szatmari</surname><given-names>I</given-names></name><name><surname>Savage</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><etal/></person-group><article-title>Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance</article-title><source>Cell Metab</source><year>2006</year><volume>4</volume><fpage>303</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">17011503</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meirhaeghe</surname><given-names>A</given-names></name><name><surname>Fajas</surname><given-names>L</given-names></name><name><surname>Helbecque</surname><given-names>N</given-names></name><name><surname>Cottel</surname><given-names>D</given-names></name><name><surname>Lebel</surname><given-names>P</given-names></name><name><surname>Dallongeville</surname><given-names>J</given-names></name><etal/></person-group><article-title>A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans</article-title><source>Hum Mol Genet</source><year>1998</year><volume>7</volume><fpage>435</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">9467001</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>CJ</given-names></name><name><surname>Beamer</surname><given-names>BA</given-names></name><name><surname>Negri</surname><given-names>C</given-names></name><name><surname>Silver</surname><given-names>K</given-names></name><name><surname>Brown</surname><given-names>KA</given-names></name><name><surname>Yarnall</surname><given-names>DP</given-names></name><etal/></person-group><article-title>Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR gamma 2 missense mutation</article-title><source>Biochem Biophys Res Commun</source><year>1997</year><volume>241</volume><fpage>270</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9425261</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#246;ssner</surname><given-names>R</given-names></name><name><surname>Meyer</surname><given-names>P</given-names></name><name><surname>Jankowski</surname><given-names>F</given-names></name><name><surname>K&#246;nig</surname><given-names>IR</given-names></name><name><surname>Kr&#252;ger</surname><given-names>U</given-names></name><name><surname>Kammerer</surname><given-names>S</given-names></name><etal/></person-group><article-title>Variations in the peroxisome proliferator-activated receptor-gamma gene and melanoma risk</article-title><source>Cancer Lett</source><year>2007</year><volume>246</volume><fpage>218</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">16713673</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>SA</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Hsueh</surname><given-names>WC</given-names></name><name><surname>Pineda</surname><given-names>P</given-names></name><name><surname>Beamer</surname><given-names>BA</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><etal/></person-group><article-title>The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans</article-title><source>Int J Obes Relat Metab Disord</source><year>2000</year><volume>24</volume><fpage>522</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10805513</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornage</surname><given-names>M</given-names></name><name><surname>Jacobs</surname><given-names>DR</given-names></name><name><surname>Steffes</surname><given-names>MW</given-names></name><name><surname>Gross</surname><given-names>MD</given-names></name><name><surname>Bray</surname><given-names>MS</given-names></name><name><surname>Schreiner</surname><given-names>PJ</given-names></name></person-group><article-title>Inverse effects of the PPAR (gamma) 2 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and whites. The CARDIA study</article-title><source>Metabolism</source><year>2005</year><volume>54</volume><fpage>910</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15988700</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>ES</given-names></name><name><surname>Corella</surname><given-names>D</given-names></name><name><surname>Deurenberg-Yap</surname><given-names>M</given-names></name><name><surname>Adiconis</surname><given-names>X</given-names></name><name><surname>Chew</surname><given-names>SK</given-names></name><name><surname>Tan</surname><given-names>CE</given-names></name><etal/></person-group><article-title>Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population</article-title><source>J Lipid Res</source><year>2004</year><volume>45</volume><fpage>674</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">14729856</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moffett</surname><given-names>SP</given-names></name><name><surname>Feingold</surname><given-names>E</given-names></name><name><surname>Barmada</surname><given-names>MM</given-names></name><name><surname>Damcott</surname><given-names>CM</given-names></name><name><surname>Marshall</surname><given-names>JA</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><etal/></person-group><article-title>The C161 &#8594;T polymorphism in peroxisome proliferator-activated receptor gamma, but not P12A, is associated with insulin resistance in Hispanic and non-Hispanic white women: Evidence for another functional variant in peroxisome proliferator-activated receptor gamma</article-title><source>Metabolism</source><year>2005</year><volume>54</volume><fpage>1552</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16253648</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name></person-group><article-title>Association between C1431T polymorphism in peroxisome proliferator-activated receptor-&#947; gene and coronary artery disease in Chinese Han population</article-title><source>Mol Biol Rep</source><year>2012</year><volume>39</volume><fpage>1863</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21643757</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>J</given-names></name><name><surname>Xiong</surname><given-names>S</given-names></name><name><surname>Chao</surname><given-names>S</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title>PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus</article-title><source>Cardiovasc Diabetol</source><year>2010</year><volume>9</volume><fpage>13</fpage><pub-id pub-id-type="pmid">20334678</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>LL</given-names></name><name><surname>Hua</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>RK</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><article-title>Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population</article-title><source>Arch Med Res</source><year>2009</year><volume>40</volume><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">19237017</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dongxia</surname><given-names>L</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name><name><surname>Lisong</surname><given-names>L</given-names></name><name><surname>Jincheng</surname><given-names>G</given-names></name></person-group><article-title>Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome</article-title><source>Circ J</source><year>2008</year><volume>72</volume><fpage>551</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">18362424</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Urano</surname><given-names>T</given-names></name><name><surname>Hosoi</surname><given-names>T</given-names></name><name><surname>Miyao</surname><given-names>M</given-names></name><name><surname>Hoshino</surname><given-names>S</given-names></name><name><surname>Fujita</surname><given-names>M</given-names></name><etal/></person-group><article-title>Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma gene: PPARgamma expression in osteoblasts</article-title><source>Biochem Biophys Res Commun</source><year>1999</year><volume>260</volume><fpage>122</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10381354</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanada</surname><given-names>K</given-names></name><name><surname>Iemitsu</surname><given-names>M</given-names></name><name><surname>Murakami</surname><given-names>H</given-names></name><name><surname>Tabata</surname><given-names>I</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Gando</surname><given-names>Y</given-names></name><etal/></person-group><article-title>PPAR&#947;2 C1431T genotype increases metabolic syndrome risk in young men with low cardiorespiratory fitness</article-title><source>Physiol Genomics</source><year>2011</year><volume>43</volume><fpage>103</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21156835</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Gajalakshmi</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Kuriki</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name><etal/></person-group><article-title>Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population</article-title><source>Cancer Sci</source><year>2005</year><volume>96</volume><fpage>507</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">16108832</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XL</given-names></name><name><surname>Oosterhof</surname><given-names>J</given-names></name><name><surname>Duarte</surname><given-names>N</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptor gamma C161 &#8594;T polymorphism and coronary artery disease</article-title><source>Cardiovasc Res</source><year>1999</year><volume>44</volume><fpage>588</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">10690291</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>V</given-names></name><name><surname>Christensen</surname><given-names>J</given-names></name><name><surname>Ernst</surname><given-names>A</given-names></name><name><surname>Jacobsen</surname><given-names>BA</given-names></name><name><surname>Tj&#248;nneland</surname><given-names>A</given-names></name><name><surname>Krarup</surname><given-names>HB</given-names></name><etal/></person-group><article-title>Polymorphisms in NF-&#954;B, PXR, LXR, PPAR&#947; and risk of inflammatory bowel disease</article-title><source>World J Gastroenterol</source><year>2011</year><volume>17</volume><fpage>197</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">21245992</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulsen</surname><given-names>P</given-names></name><name><surname>Andersen</surname><given-names>G</given-names></name><name><surname>Fenger</surname><given-names>M</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Echwald</surname><given-names>SM</given-names></name><name><surname>V&#248;lund</surname><given-names>A</given-names></name><etal/></person-group><article-title>Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: Thrifty genotype, thrifty phenotype, or both?</article-title><source>Diabetes</source><year>2003</year><volume>52</volume><fpage>194</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12502512</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dallongeville</surname><given-names>J</given-names></name><name><surname>Iribarren</surname><given-names>C</given-names></name><name><surname>Ferri&#232;res</surname><given-names>J</given-names></name><name><surname>Lyon</surname><given-names>L</given-names></name><name><surname>Evans</surname><given-names>A</given-names></name><name><surname>Go</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Peroxisome proliferator-activated receptor gamma polymorphisms and coronary heart disease</article-title><source>PPAR Res</source><year>2009</year><volume>2009</volume><fpage>543746</fpage><pub-id pub-id-type="pmid">20016803</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orio</surname><given-names>F</given-names><suffix>Jr</suffix></name><name><surname>Matarese</surname><given-names>G</given-names></name><name><surname>Di Biase</surname><given-names>S</given-names></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>Labella</surname><given-names>D</given-names></name><name><surname>Sanna</surname><given-names>V</given-names></name><etal/></person-group><article-title>Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome</article-title><source>J Clin Endocrinol Metab</source><year>2003</year><volume>88</volume><fpage>5887</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">14671186</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>M</given-names></name><name><surname>Rett</surname><given-names>K</given-names></name><name><surname>Maerker</surname><given-names>E</given-names></name><name><surname>Volk</surname><given-names>A</given-names></name><name><surname>Haist</surname><given-names>K</given-names></name><name><surname>Deninger</surname><given-names>M</given-names></name><etal/></person-group><article-title>The silent PPARgamma exon 6 CAC (His)&#8594;CAT (His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany</article-title><source>Exp Clin Endocrinol Diabetes</source><year>2000</year><volume>108</volume><fpage>341</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10989952</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="webpage"><source>dbSNP. (Database of Single Nucleotide Polymorphisms), National Center for Biotechnology Information, National Library of Medicine. (dbSNP)</source><year>2012</year><comment>Available from: <uri xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/2012">http://www.ncbi.nlm.nih.gov/SNP/2012</uri></comment></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Yun</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>L</given-names></name><name><surname>Su</surname><given-names>X</given-names></name></person-group><article-title>Association of the PPARgamma2 gene Pro12Ala variant with primary hypertension and metabolic lipid disorders in Han Chinese of Inner Mongolia</article-title><source>Genet Mol Res</source><year>2010</year><volume>9</volume><fpage>1312</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">20623456</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>LL</given-names></name><name><surname>Ma</surname><given-names>XL</given-names></name><name><surname>Ran</surname><given-names>JX</given-names></name><name><surname>Sun</surname><given-names>XF</given-names></name><name><surname>Xu</surname><given-names>LM</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><etal/></person-group><article-title>Genetic polymorphism of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjects</article-title><source>Clin Exp Pharmacol Physiol</source><year>2008</year><volume>35</volume><fpage>187</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">17941898</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaydashev</surname><given-names>I</given-names></name><name><surname>Rasin</surname><given-names>A</given-names></name><name><surname>Shlykova</surname><given-names>O</given-names></name><name><surname>Gorbas</surname><given-names>I</given-names></name><name><surname>Smirnova</surname><given-names>I</given-names></name><name><surname>Petrushov</surname><given-names>A</given-names></name><etal/></person-group><article-title>Frequency of Pro12Ala-polymorphism of the Gene PPAR&#947;2 in the Ukrainian population and its possible relation to the development of the metabolic syndrome</article-title><source>Cytol Genet</source><year>2007</year><volume>41</volume><fpage>297</fpage><lpage>302</lpage></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragojevi&#269;</surname><given-names>J</given-names></name><name><surname>Ostanek</surname><given-names>B</given-names></name><name><surname>Mencej-Bedra&#269;</surname><given-names>S</given-names></name><name><surname>Komadina</surname><given-names>R</given-names></name><name><surname>Pre&#382;elj</surname><given-names>J</given-names></name><name><surname>Marc</surname><given-names>J</given-names></name></person-group><article-title>PPARG gene promoter polymorphism is associated with non-traumatic hip fracture risk in the elderly Slovenian population: A pilot study</article-title><source>Clin Biochem</source><year>2011</year><volume>44</volume><fpage>1085</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21756892</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>WH</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Bray</surname><given-names>MS</given-names></name><name><surname>Brancati</surname><given-names>FL</given-names></name><etal/></person-group><article-title>Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: The Atherosclerosis Risk in Communities Study</article-title><source>Diabetes</source><year>2003</year><volume>52</volume><fpage>1568</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">12765972</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farjadian</surname><given-names>S</given-names></name><name><surname>Moqadam</surname><given-names>FA</given-names></name><name><surname>Ghaderi</surname><given-names>A</given-names></name></person-group><article-title>HLA class II gene polymorphism in Parsees and Zoroastrians of Iran</article-title><source>Int J Immunogenet</source><year>2006</year><volume>33</volume><fpage>185</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">16712649</pub-id></element-citation></ref></ref-list></back></article>